2020
DOI: 10.15585/mmwr.mm6928a1
|View full text |Cite
|
Sign up to set email alerts
|

Vital Signs: Prescription Opioid Pain Reliever Use During Pregnancy — 34 U.S. Jurisdictions, 2019

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
76
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 148 publications
(88 citation statements)
references
References 15 publications
2
76
0
Order By: Relevance
“…She is one of an estimated 21,000 pregnant women who reported misuse of opioids in the past month in the United States [ 1 ]. In a recent Centers for Disease Control and Prevention study, 6.6% of women reported using prescription opioids during pregnancy, among whom 21.2% reported misuse (ie, illicit use or nonmedical use of prescription opioids) [ 2 ]. Pregnant women who misuse opioids face obstetric complications, and their infants are at risk of developing neonatal abstinence syndrome (NAS), which can impede neonatal growth and increase the risk of other physical and developmental problems [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…She is one of an estimated 21,000 pregnant women who reported misuse of opioids in the past month in the United States [ 1 ]. In a recent Centers for Disease Control and Prevention study, 6.6% of women reported using prescription opioids during pregnancy, among whom 21.2% reported misuse (ie, illicit use or nonmedical use of prescription opioids) [ 2 ]. Pregnant women who misuse opioids face obstetric complications, and their infants are at risk of developing neonatal abstinence syndrome (NAS), which can impede neonatal growth and increase the risk of other physical and developmental problems [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…Other pregnancy concerns and posts with unspecified support needs were excluded from further analysis because they do not pertain to opioid use. The women had different self-management support needs according to their recovery stages (χ 2 15 =69.5; P<.001). The absolute value of a standardized residual (r std ) greater than 2 indicates a strong (dis)association (Figure 2), on which we will elaborate next.…”
Section: Study Aim 2: Self-management Support Needsmentioning
confidence: 99%
“…Prescription opioid use among pregnant women has risen significantly since 2000 [ 2 , 3 ]. In 2019, 6.6% of pregnant women in the US reported prescription opioid use [ 4 ], though previous studies have found that 14 to 22% of Medicaid-enrolled pregnant women filled at least one opioid prescription during pregnancy [ 5 ]. In addition to harms to the mother, opioid use during pregnancy has also been associated with poor infant outcomes including neonatal abstinence syndrome (NAS).…”
Section: Introductionmentioning
confidence: 99%